HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
204:@0.078769:0.033217:0.109813:0.033217:0.109813:0.013052:0.078769:0.013052:0.010348:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
more severe disease in later years that is likely to scar. In :@0.076190:0.084931:0.485130:0.084931:0.485130:0.069149:0.076190:0.069149:0.014182:0.009903:0.004551:0.009827:0.003946:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.003946:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.003961:0.003024:0.009223:0.003961:0.003024:0.010326:0.005125:0.009827:0.004551:0.003946:0.008104:0.009827:0.010326:0.004551:0.005866:0.003961:0.005125:0.009223:0.010326:0.005125:0.003946:0.003024:0.005866:0.003961:0.003024:0.003024:0.007590:0.009827:0.003024:0.008104:0.003961:0.005125:0.009903:0.003946:0.005866:0.009782:0.010326:0.004551:0.004188:0.003946:0.003417:0.009223:0.004188
severe or recalcitrant cases of both neonatal and infan-:@0.076190:0.099132:0.480972:0.099132:0.480972:0.083350:0.076190:0.083350:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.003508:0.009903:0.004551:0.003508:0.004551:0.009827:0.009782:0.010326:0.003024:0.009782:0.003024:0.005125:0.004551:0.010326:0.009223:0.005125:0.003508:0.009782:0.010326:0.005866:0.009827:0.005866:0.003508:0.009903:0.004747:0.003508:0.010311:0.009903:0.005125:0.009223:0.003508:0.009223:0.009827:0.009903:0.009223:0.010326:0.005125:0.010326:0.003024:0.003508:0.010326:0.009223:0.010357:0.003508:0.003024:0.009223:0.004747:0.010326:0.009223:0.005020
tile acne, a work-up for congenital adrenal hyperplasia, :@0.076190:0.113333:0.485115:0.113333:0.485115:0.097550:0.076190:0.097550:0.005125:0.003024:0.003024:0.009827:0.003629:0.010326:0.009782:0.009223:0.009827:0.004188:0.003629:0.010326:0.003629:0.012564:0.009903:0.004551:0.007590:0.005020:0.009192:0.010311:0.003629:0.004747:0.009903:0.004551:0.003629:0.009782:0.009903:0.009223:0.010175:0.009812:0.009223:0.003024:0.005125:0.010326:0.003024:0.003629:0.010326:0.010357:0.004551:0.009827:0.009223:0.010326:0.003024:0.003629:0.009223:0.008104:0.010311:0.009827:0.004551:0.010311:0.003024:0.010326:0.005866:0.003024:0.010326:0.004188:0.004188
a virilising  tumour,  or  underlying  endocrinopathy  and :@0.076190:0.127534:0.485115:0.127534:0.485115:0.111751:0.076190:0.111751:0.010326:0.007484:0.008376:0.003024:0.004551:0.003024:0.003024:0.003024:0.005866:0.003024:0.009238:0.010175:0.004188:0.003281:0.005125:0.009192:0.014182:0.009888:0.009192:0.004551:0.004188:0.004188:0.003281:0.009903:0.004551:0.004188:0.003281:0.009192:0.009223:0.010357:0.009827:0.004551:0.003024:0.008104:0.003024:0.009223:0.010175:0.004188:0.003281:0.009827:0.009223:0.010357:0.009903:0.009782:0.004551:0.003024:0.009223:0.009903:0.010311:0.010326:0.005125:0.009223:0.008104:0.004188:0.003281:0.010326:0.009223:0.010357:0.004188
exclusion of infectious cause is warranted.:@0.076190:0.141735:0.383515:0.141735:0.383515:0.125952:0.076190:0.125952:0.009827:0.007257:0.009782:0.003024:0.009192:0.005866:0.003024:0.009903:0.009223:0.004188:0.009903:0.004747:0.004188:0.003024:0.009223:0.004747:0.009827:0.009782:0.005125:0.003024:0.009903:0.009192:0.005866:0.004188:0.009782:0.010326:0.009192:0.005866:0.009827:0.004188:0.003024:0.005866:0.004188:0.012564:0.010326:0.004551:0.004551:0.010326:0.009223:0.005125:0.009827:0.010357:0.004188
4:@0.383495:0.136425:0.388353:0.136425:0.388353:0.127271:0.383495:0.127271:0.004858
Treatment of acne vulgaris is summarised in Figure 1.:@0.090476:0.155922:0.472126:0.155922:0.472126:0.140139:0.090476:0.140139:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.009903:0.004747:0.004188:0.010326:0.009782:0.009223:0.009827:0.004188:0.008376:0.009192:0.003024:0.010175:0.010326:0.004551:0.003024:0.005866:0.004188:0.003024:0.005866:0.004188:0.005866:0.009192:0.014182:0.014182:0.010326:0.004551:0.003024:0.005866:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.007333:0.003024:0.010175:0.009192:0.004551:0.009827:0.004188:0.008376:0.004188
Acne-scarring:@0.076190:0.187191:0.192439:0.187191:0.192439:0.168859:0.076190:0.168859:0.012431:0.010751:0.010079:0.010751:0.007056:0.007392:0.010751:0.011087:0.005376:0.005376:0.004032:0.010079:0.011087
Acne scars are for all intents and purposes permanent. :@0.076190:0.203560:0.485145:0.203560:0.485145:0.187778:0.076190:0.187778:0.011188:0.009782:0.009223:0.009827:0.004762:0.005866:0.009782:0.010326:0.004551:0.005866:0.004778:0.010326:0.004551:0.009827:0.004762:0.004747:0.009903:0.004551:0.004762:0.010326:0.003024:0.003024:0.004778:0.003024:0.009223:0.005125:0.009827:0.009223:0.005125:0.005866:0.004762:0.010326:0.009223:0.010357:0.004778:0.010311:0.009192:0.004551:0.010311:0.009903:0.005866:0.009827:0.005866:0.004762:0.010311:0.009827:0.004551:0.014182:0.010326:0.009223:0.009827:0.009223:0.005125:0.004188:0.004188
Effective, rapid and lasting treatment for acne-associat-:@0.076190:0.217761:0.480942:0.217761:0.480942:0.201979:0.076190:0.201979:0.008104:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188:0.003311:0.004551:0.010326:0.010311:0.003024:0.010357:0.003311:0.010326:0.009223:0.010357:0.003311:0.003024:0.010326:0.005866:0.005125:0.003024:0.009223:0.010175:0.003311:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003296:0.004747:0.009903:0.004551:0.003296:0.010326:0.009782:0.009223:0.009827:0.005020:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.005020
ed scars is not available. prevention of scarring by iden-:@0.076190:0.231962:0.480942:0.231962:0.480942:0.216180:0.076190:0.216180:0.009827:0.010357:0.004022:0.005866:0.009782:0.010326:0.004551:0.005866:0.004037:0.003024:0.005866:0.004037:0.009223:0.009903:0.005125:0.004022:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188:0.004037:0.008950:0.004551:0.009827:0.008376:0.009812:0.009223:0.005125:0.003024:0.009903:0.009223:0.004022:0.009903:0.004747:0.004022:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175:0.004022:0.010311:0.008104:0.004037:0.003024:0.010357:0.009827:0.009223:0.005020
tification  and  effective  early  treatment  of  individuals :@0.076190:0.246163:0.485115:0.246163:0.485115:0.230381:0.076190:0.230381:0.005125:0.003024:0.003681:0.003681:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003659:0.010326:0.009223:0.010357:0.004188:0.003659:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188:0.003659:0.009827:0.010326:0.004551:0.003024:0.008104:0.004188:0.003659:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003644:0.009903:0.004747:0.004188:0.003659:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.005866:0.004188
and lesions prone to scarring is the most cost-effective :@0.076190:0.260364:0.485130:0.260364:0.485130:0.244581:0.076190:0.244581:0.010326:0.009223:0.010357:0.005337:0.003024:0.009827:0.005866:0.003024:0.009903:0.009223:0.005866:0.005337:0.010311:0.004551:0.009903:0.009223:0.009827:0.005322:0.005125:0.009903:0.005322:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175:0.005337:0.003024:0.005866:0.005337:0.005125:0.009223:0.009827:0.005322:0.014182:0.009903:0.005866:0.005125:0.005337:0.009782:0.009903:0.005866:0.005125:0.005020:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188
strategy. Risk factors for scarring include severity, dura-:@0.076190:0.274565:0.480942:0.274565:0.480942:0.258782:0.076190:0.258782:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.010175:0.008104:0.004188:0.005140:0.009177:0.003024:0.005866:0.007590:0.005156:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.005140:0.004747:0.009903:0.004551:0.005140:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175:0.005156:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005156:0.005866:0.009827:0.008376:0.009827:0.004551:0.003024:0.005125:0.008104:0.004188:0.005156:0.010357:0.009192:0.004551:0.010326:0.005020
tion  and  extent  of  inflammatory  lesions,  family  history, :@0.076190:0.288766:0.485115:0.288766:0.485115:0.272983:0.076190:0.272983:0.005125:0.003024:0.009903:0.009223:0.004188:0.002374:0.010326:0.009223:0.010357:0.004188:0.002374:0.009827:0.007257:0.005125:0.009827:0.009207:0.005125:0.004188:0.002374:0.009903:0.004747:0.004188:0.002374:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.002374:0.003024:0.009827:0.005866:0.003024:0.009903:0.009223:0.005866:0.004188:0.004188:0.002374:0.004747:0.010326:0.014182:0.003024:0.003024:0.008104:0.004188:0.002389:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.004188
manipulation of lesions and trunk localisation. A com-:@0.076190:0.302967:0.480957:0.302967:0.480957:0.287184:0.076190:0.287184:0.014182:0.010326:0.009223:0.003024:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.006305:0.009903:0.004747:0.006305:0.003024:0.009827:0.005866:0.003024:0.009903:0.009223:0.005866:0.006305:0.010326:0.009223:0.010357:0.006305:0.005125:0.004551:0.009192:0.009223:0.007590:0.006290:0.003024:0.009903:0.009782:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.006305:0.011188:0.006290:0.009782:0.009903:0.014182:0.005020
bination of treatment modalities based on the type of :@0.076190:0.317168:0.485130:0.317168:0.485130:0.301385:0.076190:0.301385:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005503:0.009903:0.004747:0.005488:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005488:0.014182:0.009903:0.010357:0.010326:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.005503:0.010311:0.010326:0.005866:0.009827:0.010357:0.005503:0.009903:0.009223:0.005488:0.005125:0.009223:0.009827:0.005488:0.005125:0.008104:0.010311:0.009827:0.005503:0.009903:0.004747:0.004188
scarring (atrophic, keloidal and hypertrophic), gives the :@0.076190:0.331369:0.485130:0.331369:0.485130:0.315586:0.076190:0.315586:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175:0.003855:0.005579:0.010326:0.005125:0.004551:0.009903:0.010311:0.009223:0.003024:0.009782:0.004188:0.003855:0.007590:0.009827:0.003024:0.009903:0.003024:0.010357:0.010326:0.003024:0.003855:0.010326:0.009223:0.010357:0.003855:0.009223:0.008104:0.010311:0.009827:0.004551:0.005125:0.004551:0.009903:0.010311:0.009223:0.003024:0.009782:0.005579:0.004188:0.003840:0.010175:0.003024:0.008376:0.009827:0.005866:0.003855:0.005125:0.009223:0.009827:0.004188
best results in the treatment of established scars. These :@0.076190:0.345569:0.485130:0.345569:0.485130:0.329787:0.076190:0.329787:0.010311:0.009827:0.005866:0.005125:0.005156:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.005156:0.003024:0.009223:0.005156:0.005125:0.009223:0.009827:0.005156:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005140:0.009903:0.004747:0.005156:0.009827:0.005866:0.005125:0.010326:0.010311:0.003024:0.003024:0.005866:0.009223:0.009827:0.010357:0.005171:0.005866:0.009782:0.010326:0.004551:0.005866:0.004188:0.005156:0.006441:0.009223:0.009827:0.005866:0.009827:0.004188
include resurfacing and lifting procedures, intralesional :@0.076190:0.359770:0.485130:0.359770:0.485130:0.343988:0.076190:0.343988:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005201:0.004551:0.009827:0.005866:0.009192:0.004551:0.004747:0.010326:0.009782:0.003024:0.009223:0.010175:0.005201:0.010326:0.009223:0.010357:0.005201:0.003024:0.003024:0.004747:0.005125:0.003024:0.009223:0.010175:0.005201:0.010311:0.004551:0.009903:0.009782:0.009827:0.010357:0.009192:0.004551:0.009827:0.005866:0.004188:0.005186:0.003024:0.009223:0.005125:0.004551:0.010326:0.003024:0.009827:0.005866:0.003024:0.009903:0.009223:0.010326:0.003024:0.004188
corticosteroids or bleomycin, cryotherapy, silicone gel :@0.076190:0.373971:0.485145:0.373971:0.485145:0.358189:0.076190:0.358189:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.006290:0.009903:0.004551:0.006290:0.010311:0.003024:0.009827:0.009903:0.014182:0.008104:0.009782:0.003024:0.009223:0.004188:0.006290:0.009782:0.004551:0.008104:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.006290:0.005866:0.003024:0.003024:0.003024:0.009782:0.009903:0.009223:0.009827:0.006305:0.010175:0.009827:0.003024:0.004188
sheeting,  laser  therapy  and  surgical excision  with  or :@0.076190:0.388172:0.485130:0.388172:0.485130:0.372390:0.076190:0.372390:0.005866:0.009223:0.009827:0.009827:0.005125:0.003024:0.009223:0.010175:0.004188:0.004188:0.004248:0.003024:0.010326:0.005866:0.009827:0.004551:0.004188:0.004248:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004248:0.010326:0.009223:0.010357:0.004188:0.004248:0.005866:0.009192:0.004551:0.010175:0.003024:0.009782:0.010326:0.003024:0.008452:0.009827:0.007257:0.009782:0.003024:0.005866:0.003024:0.009903:0.009223:0.004188:0.004248:0.012564:0.003024:0.005125:0.009223:0.004188:0.004248:0.009903:0.004551:0.004188
without radiation. Treatment of acne-scarring is best left :@0.076190:0.402373:0.485145:0.402373:0.485145:0.386590:0.076190:0.386590:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.003840:0.004551:0.010326:0.010357:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.003840:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003825:0.009903:0.004747:0.003840:0.010326:0.009782:0.009223:0.009827:0.005020:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175:0.003840:0.003024:0.005866:0.003840:0.010311:0.009827:0.005866:0.005125:0.003840:0.003024:0.009827:0.004747:0.005125:0.004188
to clinicians experienced in these procedures.:@0.076190:0.416574:0.412740:0.416574:0.412740:0.400791:0.076190:0.400791:0.005125:0.009903:0.004188:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.003024:0.010326:0.009223:0.005866:0.004188:0.009827:0.007257:0.010311:0.009827:0.004551:0.003024:0.009827:0.009223:0.009782:0.009827:0.010357:0.004188:0.003024:0.009223:0.004188:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188:0.010311:0.004551:0.009903:0.009782:0.009827:0.010357:0.009192:0.004551:0.009827:0.005866:0.004188
Post-inflammatory hyperpigmentation :@0.076190:0.447801:0.388650:0.447801:0.388650:0.429469:0.076190:0.429469:0.009407:0.010751:0.007392:0.005040:0.007056:0.004032:0.010079:0.004368:0.004368:0.011087:0.015791:0.015791:0.011087:0.005040:0.010751:0.005376:0.009743:0.004704:0.010079:0.009743:0.011087:0.010751:0.005376:0.011087:0.004032:0.011087:0.015791:0.010751:0.010079:0.005040:0.011087:0.005040:0.004032:0.010751:0.010079:0.004704
Strategies to prevent post-inflammatory hyperpigmen:@0.076190:0.464171:0.475953:0.464171:0.475953:0.448388:0.076190:0.448388:0.007529:0.005125:0.004551:0.010326:0.005125:0.009827:0.010175:0.003024:0.009827:0.005866:0.006214:0.005125:0.009903:0.006214:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.006214:0.010311:0.009903:0.005866:0.005125:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.006214:0.009223:0.008104:0.010311:0.009827:0.004551:0.010311:0.003024:0.010175:0.014182:0.009827:0.009223
-:@0.475953:0.464171:0.480972:0.464171:0.480972:0.448388:0.475953:0.448388:0.005020
tation  include early recognition  of  susceptible indi-:@0.076190:0.478372:0.480942:0.478372:0.480942:0.462589:0.076190:0.462589:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.005896:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.010100:0.009827:0.010326:0.004551:0.003024:0.008104:0.010100:0.004551:0.009827:0.009782:0.009903:0.010175:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.005896:0.009903:0.004747:0.004188:0.005896:0.005866:0.009192:0.005866:0.009782:0.009827:0.010311:0.005125:0.003024:0.010311:0.003024:0.009827:0.010100:0.003024:0.009223:0.010357:0.003024:0.005020
viduals  and treatment of underlying acne-associated :@0.076190:0.492573:0.485160:0.492573:0.485160:0.476790:0.076190:0.476790:0.008376:0.003024:0.010357:0.009192:0.010326:0.003024:0.005866:0.004188:0.002918:0.010326:0.009223:0.010357:0.007091:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.007091:0.009903:0.004747:0.007091:0.009192:0.009223:0.010357:0.009827:0.004551:0.003024:0.008104:0.003024:0.009223:0.010175:0.007091:0.010326:0.009782:0.009223:0.009827:0.005020:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188
inflammation, sun protection and avoidance of lesion :@0.076190:0.506773:0.485145:0.506773:0.485145:0.490991:0.076190:0.490991:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.006184:0.005866:0.009192:0.009223:0.006184:0.010311:0.004551:0.009903:0.005125:0.009827:0.009782:0.005125:0.003024:0.009903:0.009223:0.006169:0.010326:0.009223:0.010357:0.006184:0.010326:0.008376:0.009903:0.003024:0.010357:0.010326:0.009223:0.009782:0.009827:0.006184:0.009903:0.004747:0.006184:0.003024:0.009827:0.005866:0.003024:0.009903:0.009223:0.004188
manipulation. Topical retinoids, hydroquinone,  kojic :@0.076190:0.520974:0.485145:0.520974:0.485145:0.505192:0.076190:0.505192:0.014182:0.010326:0.009223:0.003024:0.010311:0.009192:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.011354:0.006441:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.011354:0.004551:0.009827:0.005125:0.003024:0.009223:0.009903:0.003024:0.010357:0.005866:0.004188:0.011354:0.009223:0.008104:0.010357:0.004551:0.009903:0.010311:0.009192:0.003024:0.009223:0.009903:0.009223:0.009827:0.004188:0.004188:0.007151:0.007590:0.009903:0.003069:0.003024:0.009782:0.004188
acid and azelaic acid individually or  in combinations :@0.076190:0.535175:0.485160:0.535175:0.485160:0.519393:0.076190:0.519393:0.010326:0.009782:0.003024:0.010357:0.006788:0.010326:0.009223:0.010357:0.006788:0.010326:0.006426:0.009827:0.003024:0.010326:0.003024:0.009782:0.006788:0.010326:0.009782:0.003024:0.010357:0.006788:0.003024:0.009223:0.010357:0.003024:0.008376:0.003024:0.010372:0.009192:0.010326:0.003024:0.003024:0.008104:0.006788:0.009903:0.004551:0.004188:0.002585:0.003024:0.009223:0.006788:0.009782:0.009903:0.014182:0.010311:0.003024:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
that  include mild topical corticosteroids  and antioxi-:@0.076190:0.549376:0.480942:0.549376:0.480942:0.533594:0.076190:0.533594:0.005125:0.009223:0.010326:0.005125:0.004188:0.003976:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.008179:0.014182:0.003024:0.003024:0.010357:0.008179:0.005125:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.008179:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188:0.003976:0.010326:0.009223:0.010357:0.008179:0.010326:0.009223:0.005125:0.003024:0.009903:0.007257:0.003024:0.005020
dants, such as vitamin C, improve post-inflammatory hy:@0.076190:0.563577:0.475938:0.563577:0.475938:0.547794:0.076190:0.547794:0.010357:0.010326:0.009223:0.005125:0.005866:0.004188:0.003523:0.005866:0.009192:0.009782:0.009223:0.003523:0.010326:0.005866:0.003523:0.008376:0.003024:0.005125:0.010326:0.014182:0.003024:0.009223:0.003523:0.012292:0.004188:0.003523:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.003523:0.010311:0.009903:0.005866:0.005125:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.003508:0.009223:0.008104
-:@0.475938:0.563577:0.480957:0.563577:0.480957:0.547794:0.475938:0.547794:0.005020
perpigmentation. Long-term side effects of each treat-:@0.076190:0.577778:0.480957:0.577778:0.480957:0.561995:0.076190:0.561995:0.010311:0.009827:0.004551:0.010311:0.003024:0.010175:0.014182:0.009827:0.009223:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004762:0.006985:0.009903:0.009223:0.010175:0.005020:0.005125:0.009827:0.004551:0.014182:0.004762:0.005866:0.003024:0.010357:0.009827:0.004778:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004778:0.009903:0.004747:0.004778:0.009827:0.010326:0.009782:0.009223:0.004778:0.005125:0.004551:0.009827:0.010326:0.005140:0.005020
ment have to be considered when selecting treatment. :@0.076190:0.591979:0.485145:0.591979:0.485145:0.576196:0.076190:0.576196:0.014182:0.009827:0.009223:0.005125:0.003795:0.009223:0.010326:0.008376:0.009827:0.003795:0.005125:0.009903:0.003795:0.010311:0.009827:0.003795:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.003795:0.012564:0.009223:0.009827:0.009223:0.003795:0.005866:0.009827:0.003024:0.009827:0.009782:0.005125:0.003024:0.009223:0.010175:0.003795:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.004188
Chemical peels, lasers and other light therapies can also :@0.076190:0.606180:0.485100:0.606180:0.485100:0.590397:0.076190:0.590397:0.012292:0.009223:0.009827:0.014182:0.003024:0.009782:0.010326:0.003024:0.003115:0.010311:0.009827:0.009827:0.003024:0.005866:0.004188:0.003115:0.003024:0.010326:0.005866:0.009827:0.004551:0.005866:0.003115:0.010326:0.009223:0.010357:0.003115:0.009903:0.005125:0.009223:0.009827:0.004551:0.003099:0.003024:0.003024:0.010175:0.009223:0.005125:0.003115:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.003024:0.009827:0.005866:0.003115:0.009782:0.010326:0.009223:0.003115:0.010326:0.003024:0.005866:0.009903:0.004188
be used, but can themselves cause post-inflammatory :@0.076190:0.620381:0.485115:0.620381:0.485115:0.604598:0.076190:0.604598:0.010311:0.009827:0.005428:0.009192:0.005866:0.009827:0.010357:0.004188:0.005428:0.010311:0.009192:0.005125:0.005428:0.009782:0.010326:0.009223:0.005428:0.005125:0.009223:0.009827:0.014182:0.005866:0.009827:0.003024:0.008376:0.009827:0.005866:0.005428:0.009782:0.010326:0.009192:0.005866:0.009827:0.005428:0.010311:0.009903:0.005866:0.005125:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188
hyperpigmentation  and should be used with caution. :@0.076190:0.634582:0.485130:0.634582:0.485130:0.618799:0.076190:0.618799:0.009223:0.008104:0.010311:0.009827:0.004551:0.010311:0.003024:0.010175:0.014182:0.009827:0.009223:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.002419:0.010326:0.009223:0.010357:0.006622:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.006622:0.010311:0.009827:0.006622:0.009192:0.005866:0.009827:0.010357:0.006622:0.012564:0.003024:0.005125:0.009223:0.006622:0.009782:0.010326:0.009192:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188
The low cost-to-benefit ratio of procedural therapies un:@0.076190:0.648782:0.475923:0.648782:0.475923:0.633000:0.076190:0.633000:0.006441:0.009223:0.009827:0.003629:0.003024:0.009903:0.012564:0.003644:0.009782:0.009903:0.005866:0.005125:0.005020:0.005125:0.009903:0.005020:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.003629:0.004551:0.010326:0.005125:0.003024:0.009903:0.003629:0.009903:0.004747:0.003629:0.010311:0.004551:0.009903:0.009782:0.009827:0.010357:0.009192:0.004551:0.010326:0.003024:0.003629:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.003024:0.009827:0.005866:0.003644:0.009192:0.009223
-:@0.475923:0.648782:0.480942:0.648782:0.480942:0.633000:0.475923:0.633000:0.005020
dermines their utility in treating post-inflammatory hyper:@0.076190:0.662983:0.475923:0.662983:0.475923:0.647201:0.076190:0.647201:0.010357:0.009827:0.004551:0.014182:0.003024:0.009223:0.009827:0.005866:0.003402:0.005125:0.009223:0.009827:0.003024:0.004551:0.003387:0.009192:0.005125:0.003024:0.003024:0.003024:0.005125:0.008104:0.003402:0.003024:0.009223:0.003402:0.005125:0.004551:0.009827:0.010326:0.005125:0.003024:0.009223:0.010160:0.003402:0.010311:0.009903:0.005866:0.005125:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.003387:0.009223:0.008104:0.010311:0.009827:0.004551
-:@0.475923:0.662983:0.480942:0.662983:0.480942:0.647201:0.475923:0.647201:0.005020
pigmentation.:@0.076190:0.677184:0.179846:0.677184:0.179846:0.661402:0.076190:0.661402:0.010311:0.003024:0.010175:0.014182:0.009827:0.009223:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
5:@0.179838:0.671844:0.184697:0.671844:0.184697:0.662690:0.179838:0.662690:0.004858
inDiCAtiOns fOr referrAl :@0.076190:0.710088:0.325654:0.710088:0.325654:0.689923:0.076190:0.689923:0.005174:0.013674:0.012935:0.005174:0.014413:0.013674:0.007761:0.005174:0.015522:0.013674:0.009609:0.005174:0.008870:0.015522:0.010718:0.005174:0.010718:0.009609:0.008870:0.009609:0.010718:0.010718:0.013674:0.008131:0.005174
Most patients with acne can be managed in primary :@0.076190:0.726064:0.485130:0.726064:0.485130:0.710281:0.076190:0.710281:0.013894:0.009903:0.005866:0.005125:0.006350:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.006365:0.012564:0.003024:0.005125:0.009223:0.006365:0.010326:0.009782:0.009223:0.009827:0.006350:0.009782:0.010326:0.009223:0.006350:0.010311:0.009827:0.006365:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.010357:0.006350:0.003024:0.009223:0.006365:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.004188
care. However, referral to a specialist is advised if they: :@0.076190:0.740265:0.480504:0.740265:0.480504:0.724482:0.076190:0.724482:0.009782:0.010326:0.004551:0.009827:0.004188:0.004188:0.010326:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.010326:0.003024:0.004188:0.005125:0.009903:0.004188:0.010326:0.004188:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.005125:0.004188:0.003024:0.005866:0.004188:0.010326:0.010357:0.008376:0.003024:0.005866:0.009827:0.010357:0.004188:0.003024:0.004747:0.004188:0.005125:0.009223:0.009827:0.008104:0.004188:0.004188
•  fail to respond or tolerate standard therapy:@0.076190:0.754466:0.410064:0.754466:0.410064:0.738683:0.076190:0.738683:0.009162:0.004188:0.003447:0.004747:0.010326:0.003024:0.003024:0.004188:0.005125:0.009903:0.004188:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.004188:0.009903:0.004551:0.004188:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.004188:0.005866:0.005125:0.010326:0.009223:0.010357:0.010326:0.004551:0.010357:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104
•  have severe forms, such as acne conglobata, acne :@0.076190:0.768667:0.485145:0.768667:0.485145:0.752884:0.076190:0.752884:0.009162:0.004188:0.003447:0.009223:0.010326:0.008376:0.009827:0.005382:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.005382:0.004747:0.009903:0.004551:0.014182:0.005866:0.004188:0.005367:0.005866:0.009192:0.009782:0.009223:0.005382:0.010326:0.005866:0.005382:0.010326:0.009782:0.009223:0.009827:0.005382:0.009782:0.009903:0.009223:0.010175:0.003024:0.009903:0.010311:0.010326:0.005125:0.010326:0.004188:0.005367:0.010326:0.009782:0.009223:0.009827:0.004188
fulminans or cystic acne:@0.092988:0.782867:0.269654:0.782867:0.269654:0.767085:0.092988:0.767085:0.004747:0.009192:0.003024:0.014182:0.003024:0.009223:0.010326:0.009223:0.005866:0.004188:0.009903:0.004551:0.004188:0.009782:0.008104:0.005866:0.005125:0.003024:0.009782:0.004188:0.010326:0.009782:0.009223:0.009827
•  have a high risk of scarring:@0.076190:0.797068:0.286829:0.797068:0.286829:0.781286:0.076190:0.781286:0.009162:0.004188:0.003447:0.009223:0.010326:0.008376:0.009827:0.004188:0.010326:0.004188:0.009223:0.003024:0.010175:0.009223:0.004188:0.004551:0.003024:0.005866:0.007590:0.004188:0.009903:0.004747:0.004188:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175
•  are at risk of severe psychosocial complications:@0.076190:0.811269:0.440816:0.811269:0.440816:0.795487:0.076190:0.795487:0.009162:0.004188:0.003447:0.010326:0.004551:0.009827:0.004188:0.010326:0.005125:0.004188:0.004551:0.003024:0.005866:0.007590:0.004188:0.009903:0.004747:0.004188:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188:0.010311:0.005866:0.008104:0.009782:0.009223:0.009903:0.005866:0.009903:0.009782:0.003024:0.010326:0.003024:0.004188:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866
•  have acne that is associated with an underlying en:@0.076190:0.825470:0.475938:0.825470:0.475938:0.809688:0.076190:0.809688:0.009162:0.004188:0.003447:0.009223:0.010326:0.008376:0.009827:0.005216:0.010326:0.009782:0.009223:0.009827:0.005216:0.005125:0.009223:0.010326:0.005125:0.005201:0.003024:0.005866:0.005216:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.005216:0.012564:0.003024:0.005125:0.009223:0.005216:0.010326:0.009223:0.005216:0.009192:0.009223:0.010357:0.009827:0.004551:0.003024:0.008104:0.003024:0.009223:0.010175:0.005216:0.009827:0.009223
-:@0.475938:0.825470:0.480957:0.825470:0.480957:0.809688:0.475938:0.809688:0.005020
docrinological cause or another systemic disorder:@0.092988:0.839671:0.457765:0.839671:0.457765:0.823888:0.092988:0.823888:0.010357:0.009903:0.009782:0.004551:0.003024:0.009223:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004188:0.009782:0.010326:0.009192:0.005866:0.009827:0.004188:0.009903:0.004551:0.004188:0.010326:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.004188:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.003024:0.009782:0.004188:0.010357:0.003024:0.005866:0.009903:0.004551:0.010357:0.009827:0.004551
•  require management of complications such as post-:@0.076190:0.853872:0.480942:0.853872:0.480942:0.838089:0.076190:0.838089:0.009162:0.004188:0.003447:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.004944:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004929:0.009903:0.004747:0.004944:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004944:0.005866:0.009192:0.009782:0.009223:0.004944:0.010326:0.005866:0.004944:0.010311:0.009903:0.005866:0.005125:0.005020
inflammatory hyperpigmentation and scarring.:@0.092988:0.868073:0.434905:0.868073:0.434905:0.852290:0.092988:0.852290:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188:0.009223:0.008104:0.010311:0.009827:0.004551:0.010311:0.003024:0.010175:0.014182:0.009827:0.009223:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.010326:0.009223:0.010357:0.004188:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175:0.004188
COnClusiOns:@0.076190:0.900990:0.207760:0.900990:0.207760:0.880825:0.076190:0.880825:0.014413:0.015522:0.013674:0.014413:0.008131:0.011826:0.009609:0.005174:0.015522:0.013674:0.009609
Although  acne is common  and non-life-threatening, :@0.076190:0.916966:0.485145:0.916966:0.485145:0.901184:0.076190:0.901184:0.011188:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.004188:0.004551:0.010326:0.009782:0.009223:0.009827:0.008754:0.003024:0.005866:0.008754:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.004188:0.004551:0.010326:0.009223:0.010357:0.008754:0.009223:0.009903:0.009223:0.005020:0.003024:0.003024:0.004747:0.009827:0.005020:0.005125:0.009223:0.004551:0.009827:0.010326:0.005125:0.009827:0.009223:0.003024:0.009223:0.010175:0.004188:0.004188
it has a major impact on the  quality of life it affects. :@0.076190:0.931167:0.485145:0.931167:0.485145:0.915385:0.076190:0.915385:0.003024:0.005125:0.006879:0.009223:0.010326:0.005866:0.006879:0.010326:0.006879:0.014182:0.010326:0.003069:0.009903:0.004551:0.006879:0.003024:0.014182:0.010311:0.010326:0.009782:0.005125:0.006879:0.009903:0.009223:0.006879:0.005125:0.009223:0.009827:0.004188:0.002676:0.010311:0.009192:0.010326:0.003024:0.003024:0.005125:0.008104:0.006879:0.009903:0.004747:0.006879:0.003024:0.003024:0.004747:0.009827:0.006879:0.003024:0.005125:0.006879:0.010326:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.004188
Recent  adjustments to management strategies with :@0.076190:0.945368:0.485145:0.945368:0.485145:0.929585:0.076190:0.929585:0.009177:0.009827:0.009782:0.009827:0.009223:0.005125:0.004188:0.005110:0.010326:0.010357:0.003069:0.009192:0.005866:0.005125:0.014182:0.009827:0.009223:0.005125:0.005866:0.009313:0.005125:0.009903:0.009313:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.009313:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.010175:0.003024:0.009827:0.005866:0.009313:0.012564:0.003024:0.005125:0.009223:0.004188
increasing data include early and appropriately more :@0.519042:0.084932:0.927997:0.084932:0.927997:0.069149:0.519042:0.069149:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.005881:0.010357:0.010326:0.005125:0.010326:0.005881:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.005881:0.009827:0.010326:0.004551:0.003024:0.008104:0.005881:0.010326:0.009223:0.010357:0.005881:0.010326:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.003024:0.008104:0.005881:0.014182:0.009903:0.004551:0.009827:0.004188
aggressive treatment  to  prevent  life-long scarring;  ex-:@0.519042:0.099041:0.923794:0.099041:0.923794:0.083258:0.519042:0.083258:0.010326:0.010175:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.008376:0.009827:0.006577:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.002374:0.005125:0.009903:0.004188:0.002374:0.010311:0.004551:0.009827:0.008376:0.009827:0.009223:0.005125:0.004188:0.002374:0.003024:0.003024:0.004747:0.009827:0.005020:0.003024:0.009903:0.009223:0.010175:0.006577:0.005866:0.009782:0.010326:0.004551:0.004551:0.003024:0.009223:0.010175:0.004188:0.004188:0.002374:0.009827:0.007257:0.005020
tending treatment with isotretinoin for two months af-:@0.519042:0.113149:0.923809:0.113149:0.923809:0.097366:0.519042:0.097366:0.005125:0.009827:0.009223:0.010357:0.003024:0.009223:0.010175:0.006622:0.005125:0.004551:0.009827:0.010326:0.005125:0.014167:0.009827:0.009223:0.005125:0.006622:0.012564:0.003024:0.005125:0.009223:0.006622:0.003024:0.005866:0.009903:0.005125:0.004551:0.009827:0.005125:0.003024:0.009223:0.009903:0.003024:0.009223:0.006622:0.004747:0.009903:0.004551:0.006622:0.005125:0.012564:0.009903:0.006622:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.006622:0.010326:0.004747:0.005020
ter resolution to reduce the risk of recurrence; and the :@0.519042:0.127258:0.927997:0.127258:0.927997:0.111475:0.519042:0.111475:0.005125:0.009827:0.004551:0.005307:0.004551:0.009827:0.005866:0.009903:0.003024:0.009192:0.005125:0.003024:0.009903:0.009223:0.005322:0.005125:0.009903:0.005322:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.005307:0.005125:0.009223:0.009827:0.005307:0.004551:0.003024:0.005866:0.007590:0.005322:0.009903:0.004747:0.005322:0.004551:0.009827:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.009782:0.009827:0.004188:0.005292:0.010326:0.009223:0.010357:0.005322:0.005125:0.009223:0.009827:0.004188
use of higher cumulative doses of isotretinoin in severe :@0.519042:0.141366:0.927982:0.141366:0.927982:0.125584:0.519042:0.125584:0.009192:0.005866:0.009827:0.005292:0.009903:0.004747:0.005292:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.005292:0.009782:0.009192:0.014182:0.009192:0.003024:0.010326:0.005125:0.003024:0.008376:0.009827:0.005292:0.010357:0.009903:0.005866:0.009827:0.005866:0.005292:0.009903:0.004747:0.005292:0.003024:0.005866:0.009903:0.005125:0.004551:0.009827:0.005125:0.003024:0.009223:0.009903:0.003024:0.009223:0.005292:0.003024:0.009223:0.005292:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188
recalcitrant cases. The indications, dosing, duration, ef-:@0.519042:0.155475:0.923809:0.155475:0.923809:0.139692:0.519042:0.139692:0.004551:0.009827:0.009782:0.010326:0.003024:0.009782:0.003024:0.005125:0.004551:0.010326:0.009223:0.005125:0.004581:0.009782:0.010326:0.005866:0.009827:0.005866:0.004188:0.004581:0.006441:0.009223:0.009827:0.004581:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004581:0.010357:0.009903:0.005866:0.003024:0.009223:0.010175:0.004188:0.004581:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004566:0.009827:0.004747:0.005020
ficacy and safety of using low-dose isotretinoin are yet :@0.519042:0.169583:0.928012:0.169583:0.928012:0.153801:0.519042:0.153801:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.005171:0.010326:0.009223:0.010357:0.005171:0.005866:0.010326:0.004747:0.009827:0.005125:0.008104:0.005171:0.009903:0.004747:0.005171:0.009192:0.005866:0.003024:0.009223:0.010175:0.005171:0.003024:0.009903:0.012564:0.005020:0.010357:0.009903:0.005866:0.009827:0.005171:0.003024:0.005866:0.009903:0.005125:0.004551:0.009827:0.005125:0.003024:0.009223:0.009903:0.003024:0.009223:0.005156:0.010326:0.004551:0.009827:0.005171:0.008104:0.009827:0.005125:0.004188
to be defined. Similarly, the efficacy of light therapies is :@0.519042:0.183692:0.927982:0.183692:0.927982:0.167909:0.519042:0.167909:0.005125:0.009903:0.004566:0.010311:0.009827:0.004581:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.010357:0.004188:0.004566:0.007529:0.003024:0.014182:0.003024:0.003024:0.010326:0.004551:0.003024:0.008104:0.004188:0.004581:0.005125:0.009223:0.009827:0.004566:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.004581:0.009903:0.004747:0.004566:0.003024:0.003024:0.010175:0.009223:0.005125:0.004581:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.003024:0.009827:0.005866:0.004581:0.003024:0.005866:0.004188
yet to be proven.:@0.519042:0.197800:0.646208:0.197800:0.646208:0.182018:0.519042:0.182018:0.008104:0.009827:0.005125:0.004188:0.005125:0.009903:0.004188:0.010311:0.009827:0.004188:0.010311:0.004551:0.009903:0.008376:0.009827:0.009223:0.004188
referenCes:@0.519047:0.230678:0.625485:0.230678:0.625485:0.210514:0.519047:0.210514:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1.  Bhate K, Williams HC. Epidemiology of acne vulgaris. :@0.519047:0.245138:0.843367:0.245138:0.843367:0.232863:0.519047:0.232863:0.006515:0.003257:0.003257:0.007126:0.006750:0.007173:0.008032:0.003986:0.007644:0.003810:0.006950:0.003257:0.003810:0.011289:0.002352:0.002352:0.002352:0.002352:0.008032:0.011030:0.004563:0.003822:0.008032:0.009560:0.003257:0.003810:0.006303:0.008020:0.002352:0.008055:0.007644:0.011030:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.003822:0.007702:0.003692:0.003810:0.008032:0.007608:0.007173:0.007644:0.003810:0.006515:0.007150:0.002352:0.007914:0.008032:0.003540:0.002352:0.004563:0.003257:0.003257
Br J Dermatol:@0.843932:0.245138:0.920543:0.245138:0.920543:0.232863:0.843932:0.232863:0.006750:0.003540:0.003810:0.005668:0.003810:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352
. :@0.920543:0.245138:0.927058:0.245138:0.927058:0.232863:0.920543:0.232863:0.003257:0.003257
2013;168(3):474-85.:@0.539202:0.256040:0.646247:0.256040:0.646247:0.243765:0.539202:0.243765:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
2.  Collier CN, :@0.519047:0.269510:0.602749:0.269510:0.602749:0.257234:0.519047:0.257234:0.006515:0.003257:0.003257:0.007126:0.009560:0.007702:0.002352:0.002352:0.002352:0.007644:0.003540:0.003269:0.009560:0.008702:0.003257:0.003257
et al:@0.602749:0.269510:0.628020:0.269510:0.628020:0.257234:0.602749:0.257234:0.007644:0.003986:0.003257:0.008032:0.002352
. The prevalence of acne in adults 20 years and old-:@0.628020:0.269510:0.923789:0.269510:0.923789:0.257234:0.628020:0.257234:0.003257:0.003257:0.005009:0.007173:0.007644:0.003257:0.008020:0.003540:0.007644:0.006515:0.008032:0.002352:0.007644:0.007173:0.007608:0.007644:0.003257:0.007702:0.003692:0.003257:0.008032:0.007608:0.007173:0.007644:0.003257:0.002352:0.007173:0.003269:0.008032:0.008055:0.007150:0.002352:0.003986:0.004563:0.003269:0.006515:0.006515:0.003269:0.006303:0.007644:0.008032:0.003540:0.004563:0.003257:0.008032:0.007173:0.008055:0.003269:0.007702:0.002352:0.008055:0.003904
er:@0.539202:0.280411:0.550386:0.280411:0.550386:0.268136:0.539202:0.268136:0.007644:0.003540
. J Am Acad Dermatol:@0.550386:0.280411:0.677503:0.280411:0.677503:0.268136:0.550386:0.268136:0.003257:0.003257:0.005668:0.003257:0.008702:0.011030:0.003257:0.008702:0.007608:0.008032:0.008055:0.003257:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352
. 2008;58(1):56-9.:@0.677480:0.280411:0.771495:0.280411:0.771495:0.268136:0.677480:0.268136:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.003257
3.  Del Rosso JQ, :@0.519035:0.293881:0.616355:0.293881:0.616355:0.281605:0.519035:0.281605:0.006279:0.003022:0.003257:0.007596:0.008514:0.007408:0.002117:0.003457:0.006903:0.007467:0.004327:0.004327:0.007467:0.003457:0.005433:0.010007:0.003022:0.003257
et al:@0.616555:0.293881:0.641320:0.293881:0.641320:0.281605:0.616555:0.281605:0.007408:0.003751:0.003457:0.007796:0.002352
. A closer look at truncal acne vulgaris: prevalence, :@0.641085:0.293881:0.927034:0.293881:0.927034:0.281605:0.641085:0.281605:0.003022:0.003457:0.008467:0.003457:0.007373:0.002117:0.007467:0.004327:0.007408:0.003304:0.003457:0.002117:0.007467:0.007467:0.005668:0.003457:0.007796:0.003751:0.003457:0.003751:0.003304:0.006914:0.006938:0.007373:0.007796:0.002117:0.003457:0.007796:0.007373:0.006938:0.007408:0.003457:0.006279:0.006914:0.002117:0.007679:0.007796:0.003304:0.002117:0.004327:0.003022:0.003457:0.006726:0.003304:0.007408:0.006279:0.007796:0.002117:0.007408:0.006938:0.007373:0.007408:0.003257:0.003257
severity, and clinical significance. :@0.539191:0.304782:0.724281:0.304782:0.724281:0.292507:0.539191:0.292507:0.004327:0.007408:0.006279:0.007408:0.003304:0.002117:0.003751:0.006068:0.003022:0.003022:0.007796:0.006938:0.007820:0.003022:0.007373:0.002117:0.002117:0.006938:0.002117:0.007373:0.007796:0.002117:0.003022:0.004327:0.002117:0.007679:0.006938:0.002117:0.002746:0.002746:0.007373:0.007796:0.006938:0.007373:0.007408:0.003022:0.003257
J Drugs Dermatol:@0.724046:0.304782:0.817650:0.304782:0.817650:0.292507:0.724046:0.292507:0.005433:0.003022:0.008514:0.003304:0.006914:0.007679:0.004327:0.003022:0.008514:0.007408:0.003304:0.010795:0.007796:0.003751:0.007467:0.002352
. 2007;6(6):597-600.:@0.817415:0.304782:0.919991:0.304782:0.919991:0.292507:0.817415:0.292507:0.003022:0.003022:0.006279:0.006279:0.006279:0.006279:0.003022:0.006279:0.004104:0.006279:0.004104:0.003022:0.006279:0.006279:0.006279:0.003669:0.006279:0.006279:0.006279:0.003257
4.  serna-Tamayo C, :@0.519035:0.318252:0.640673:0.318252:0.640673:0.305977:0.519035:0.305977:0.006515:0.003257:0.003257:0.007126:0.005856:0.007644:0.003540:0.007173:0.008032:0.003904:0.005009:0.008032:0.011030:0.008032:0.006303:0.007702:0.003151:0.009560:0.003257:0.003257
et al:@0.640567:0.318252:0.665732:0.318252:0.665732:0.305977:0.640567:0.305977:0.007644:0.003986:0.003151:0.008032:0.002352
. Neonatal and infantile acne vulgaris: An up-:@0.665732:0.318252:0.923777:0.318252:0.923777:0.305977:0.665732:0.305977:0.003257:0.003151:0.008702:0.007644:0.007702:0.007173:0.008032:0.003986:0.008032:0.002352:0.003151:0.008032:0.007173:0.008055:0.003151:0.002352:0.007173:0.003692:0.008032:0.007173:0.003986:0.002352:0.002352:0.007644:0.003151:0.008032:0.007608:0.007173:0.007644:0.003151:0.006515:0.007150:0.002352:0.007914:0.008032:0.003540:0.002352:0.004563:0.003257:0.003163:0.008702:0.007173:0.003151:0.007150:0.008020:0.003904
date. :@0.539191:0.329153:0.573422:0.329153:0.573422:0.316878:0.539191:0.316878:0.008055:0.008032:0.003986:0.007644:0.003257:0.003257
Cutis:@0.573422:0.329153:0.601033:0.329153:0.601033:0.316878:0.573422:0.316878:0.009560:0.007150:0.003986:0.002352:0.004563
. 2014;94(1):13-6.:@0.601033:0.329153:0.695048:0.329153:0.695048:0.316878:0.601033:0.316878:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.003257
5.  Thiboutot DM, :@0.519035:0.342623:0.622964:0.342623:0.622964:0.330348:0.519035:0.330348:0.006515:0.003257:0.003257:0.007126:0.005009:0.007173:0.002352:0.008020:0.007702:0.007150:0.003986:0.007702:0.003986:0.004621:0.008749:0.010807:0.003257:0.003257
et al:@0.624339:0.342623:0.650986:0.342623:0.650986:0.330348:0.624339:0.330348:0.007644:0.003986:0.004633:0.008032:0.002352
. practical management of acne for clinicians: :@0.650986:0.342623:0.927034:0.342623:0.927034:0.330348:0.650986:0.330348:0.003257:0.004633:0.006961:0.003540:0.008032:0.007608:0.003986:0.002352:0.007608:0.008032:0.002352:0.004633:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.004633:0.007702:0.003692:0.004633:0.008032:0.007608:0.007173:0.007644:0.004633:0.003692:0.007702:0.003540:0.004633:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.002352:0.008032:0.007173:0.004563:0.003257:0.003257
An international consensus from the Global Alliance to improve out-:@0.539191:0.353525:0.923789:0.353525:0.923789:0.341249:0.539191:0.341249:0.008702:0.007173:0.003128:0.002352:0.007173:0.003986:0.007644:0.003540:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003128:0.007608:0.007702:0.007173:0.004563:0.007644:0.007173:0.004563:0.007150:0.004563:0.003128:0.003692:0.003540:0.007702:0.011030:0.003128:0.003986:0.007173:0.007644:0.003128:0.010254:0.002352:0.007702:0.008020:0.008032:0.002352:0.003140:0.008702:0.002352:0.002352:0.002352:0.008032:0.007173:0.007608:0.007644:0.003128:0.003986:0.007702:0.003128:0.002352:0.011030:0.008020:0.003540:0.007702:0.006515:0.007644:0.003128:0.007702:0.007150:0.003986:0.003904
comes in acne:@0.539191:0.364426:0.624234:0.364426:0.624234:0.352151:0.539191:0.352151:0.007608:0.007702:0.011030:0.007644:0.004563:0.003257:0.002352:0.007173:0.003257:0.008032:0.007608:0.007173:0.007644
. J Am Acad Dermatol:@0.624222:0.364426:0.751339:0.364426:0.751339:0.352151:0.624222:0.352151:0.003257:0.003257:0.005668:0.003257:0.008702:0.011030:0.003257:0.008702:0.007608:0.008032:0.008055:0.003257:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352
. 2018;78(2 suppl 1):s1-s23 e1.:@0.751328:0.364426:0.918897:0.364426:0.918897:0.352151:0.751328:0.352151:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.003257:0.005856:0.007150:0.008020:0.008020:0.002352:0.003257:0.006515:0.004339:0.003257:0.005856:0.006515:0.003904:0.005856:0.006515:0.006515:0.003257:0.007644:0.006515:0.003257
6.  Nast A, :@0.519035:0.377896:0.583006:0.377896:0.583006:0.365620:0.519035:0.365620:0.006515:0.003257:0.003257:0.007126:0.008702:0.008032:0.004563:0.003986:0.003316:0.008702:0.003257:0.003257
et al:@0.583064:0.377896:0.608394:0.377896:0.608394:0.365620:0.583064:0.365620:0.007644:0.003986:0.003316:0.008032:0.002352
. European evidence-based (s3) guideline for the treat-:@0.608394:0.377896:0.923789:0.377896:0.923789:0.365620:0.608394:0.365620:0.003257:0.003316:0.006303:0.007150:0.003540:0.007702:0.008020:0.007644:0.008032:0.007173:0.003316:0.007644:0.006515:0.002352:0.008055:0.007644:0.007173:0.007608:0.007644:0.003904:0.008020:0.008032:0.004563:0.007644:0.008055:0.003316:0.004339:0.005856:0.006515:0.004339:0.003328:0.007914:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.003316:0.003692:0.007702:0.003540:0.003316:0.003986:0.007173:0.007644:0.003316:0.003986:0.003540:0.007644:0.008032:0.003975:0.003904
ment of acne – update 2016 – short version. :@0.539191:0.388797:0.800822:0.388797:0.800822:0.376522:0.539191:0.376522:0.011030:0.007644:0.007173:0.003986:0.004527:0.007702:0.003692:0.004527:0.008032:0.007608:0.007173:0.007644:0.004539:0.005880:0.004539:0.007150:0.008020:0.008055:0.008032:0.003986:0.007644:0.004539:0.006515:0.006515:0.006515:0.006515:0.004539:0.005880:0.004539:0.004563:0.007173:0.007702:0.003540:0.003986:0.004527:0.006515:0.007644:0.003540:0.004563:0.002352:0.007702:0.007173:0.003257:0.003257
J Eur Acad Dermatol :@0.802104:0.388797:0.927058:0.388797:0.927058:0.376522:0.802104:0.376522:0.005668:0.004539:0.006303:0.007150:0.003540:0.004527:0.008702:0.007608:0.008032:0.008055:0.004539:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352:0.003257
Venereol:@0.539191:0.399699:0.591143:0.399699:0.591143:0.387423:0.539191:0.387423:0.008255:0.007644:0.007173:0.007644:0.003540:0.007644:0.007702:0.002352
. 2016;30(8):1261-8.:@0.591131:0.399699:0.698176:0.399699:0.698176:0.387423:0.591131:0.387423:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
7.  stringer T, :@0.519024:0.413168:0.595823:0.413168:0.595823:0.400893:0.519024:0.400893:0.006515:0.003257:0.003257:0.007126:0.005856:0.003986:0.003540:0.002352:0.007173:0.007914:0.007644:0.003540:0.003116:0.005009:0.003257:0.003257
et al:@0.595694:0.413168:0.620835:0.413168:0.620835:0.400893:0.595694:0.400893:0.007644:0.003986:0.003128:0.008032:0.002352
. Clinical evidence for washing and cleansers in acne :@0.620835:0.413168:0.927046:0.413168:0.927046:0.400893:0.620835:0.400893:0.003257:0.003128:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003128:0.007644:0.006515:0.002352:0.008055:0.007644:0.007173:0.007608:0.007644:0.003128:0.003692:0.007702:0.003540:0.003116:0.009772:0.008032:0.004563:0.007173:0.002352:0.007173:0.007914:0.003128:0.008032:0.007173:0.008055:0.003128:0.007608:0.002352:0.007644:0.008032:0.007173:0.004563:0.007644:0.003540:0.004563:0.003128:0.002352:0.007173:0.003128:0.008032:0.007608:0.007173:0.007644:0.003257
vulgaris: A systematic review. :@0.539179:0.424070:0.707372:0.424070:0.707372:0.411794:0.539179:0.411794:0.006515:0.007150:0.002352:0.007914:0.008032:0.003540:0.002352:0.004563:0.003257:0.003257:0.008702:0.003257:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003257:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
J Dermatolog Treat:@0.707372:0.424070:0.816415:0.424070:0.816415:0.411794:0.707372:0.411794:0.005668:0.003257:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352:0.007702:0.007914:0.003257:0.005009:0.003540:0.007644:0.008032:0.003986
. 2018;29(7):688-93.:@0.816392:0.424070:0.923436:0.424070:0.923436:0.411794:0.816392:0.411794:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
8.  Bronsnick T, Murzaku EC, Rao BK. Diet in dermatology: part I. Atopic :@0.519012:0.437540:0.927034:0.437540:0.927034:0.425264:0.519012:0.425264:0.006515:0.003257:0.003257:0.007126:0.006750:0.003540:0.007702:0.007173:0.004563:0.007173:0.002352:0.007608:0.005903:0.003681:0.005009:0.003257:0.003681:0.010807:0.007150:0.003540:0.004998:0.008032:0.005903:0.007150:0.003681:0.006303:0.009560:0.003257:0.003681:0.007138:0.008032:0.007702:0.003681:0.006750:0.006950:0.003257:0.003681:0.008749:0.002352:0.007644:0.003986:0.003681:0.002352:0.007173:0.003681:0.008055:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257:0.003669:0.006961:0.008032:0.003540:0.003986:0.003681:0.002658:0.003257:0.003681:0.008702:0.003986:0.007702:0.008020:0.002352:0.007608:0.003257
dermatitis, acne, and nonmelanoma skin cancer:@0.539167:0.448441:0.822306:0.448441:0.822306:0.436166:0.539167:0.436166:0.008055:0.007644:0.003540:0.011030:0.008032:0.003986:0.002352:0.003986:0.002352:0.004563:0.003257:0.004151:0.008032:0.007608:0.007173:0.007644:0.003257:0.004139:0.008032:0.007173:0.008055:0.004151:0.007173:0.007702:0.007173:0.011030:0.007644:0.002352:0.008032:0.007173:0.007702:0.011030:0.008032:0.004139:0.004563:0.005903:0.002352:0.007173:0.004151:0.007608:0.008032:0.007173:0.007608:0.007644:0.003540
. J Am Acad Der-:@0.822306:0.448441:0.923765:0.448441:0.923765:0.436166:0.822306:0.436166:0.003257:0.004139:0.005668:0.004151:0.008702:0.011030:0.004139:0.008702:0.007608:0.008032:0.008055:0.004139:0.008749:0.007644:0.003540:0.003904
matol:@0.539167:0.459342:0.572270:0.459342:0.572270:0.447067:0.539167:0.447067:0.011030:0.008032:0.003986:0.007702:0.002352
. 2014;71(6):1039 e1-e12.:@0.572270:0.459342:0.710888:0.459342:0.710888:0.447067:0.572270:0.447067:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.007644:0.006515:0.003904:0.007644:0.006515:0.006515:0.003257
9.  Cervantes J, :@0.519012:0.472812:0.612898:0.472812:0.612898:0.460537:0.519012:0.460537:0.006515:0.003257:0.003257:0.007126:0.009560:0.007644:0.003540:0.006515:0.008032:0.007173:0.003986:0.007644:0.004563:0.002893:0.005668:0.003257:0.003257
et al:@0.612545:0.472812:0.637451:0.472812:0.637451:0.460537:0.612545:0.460537:0.007644:0.003986:0.002893:0.008032:0.002352
. The role of zinc in the treatment of acne: A review :@0.637451:0.472812:0.926999:0.472812:0.926999:0.460537:0.637451:0.460537:0.003257:0.002893:0.005009:0.007173:0.007644:0.002893:0.003540:0.007702:0.002352:0.007644:0.002893:0.007702:0.003692:0.002893:0.004998:0.002352:0.007173:0.007608:0.002893:0.002352:0.007173:0.002893:0.003986:0.007173:0.007644:0.002893:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.002893:0.007702:0.003692:0.002893:0.008032:0.007608:0.007173:0.007644:0.003257:0.002893:0.008702:0.002893:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257
of the literature. :@0.539167:0.483714:0.632618:0.483714:0.632618:0.471438:0.539167:0.471438:0.007702:0.003692:0.003257:0.003986:0.007173:0.007644:0.003257:0.002352:0.002352:0.003986:0.007644:0.003540:0.008032:0.003986:0.007150:0.003540:0.007644:0.003257:0.003257
Dermatol Ther:@0.632594:0.483714:0.712252:0.483714:0.712252:0.471438:0.632594:0.471438:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352:0.003257:0.005009:0.007173:0.007644:0.003540
. 2018;31(1).:@0.712240:0.483714:0.779550:0.483714:0.779550:0.471438:0.712240:0.471438:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257
10. Marson JW, Baldwin HE. New concepts, concerns, and creations in :@0.519000:0.497183:0.927011:0.497183:0.927011:0.484908:0.519000:0.484908:0.006515:0.006515:0.003257:0.003869:0.010807:0.008032:0.003540:0.004563:0.007702:0.007173:0.003904:0.005668:0.011289:0.003257:0.003904:0.006750:0.008032:0.002352:0.008067:0.009772:0.002352:0.007173:0.003916:0.008032:0.006303:0.003257:0.003904:0.008702:0.007644:0.009772:0.003904:0.007608:0.007702:0.007173:0.007608:0.007644:0.008020:0.003986:0.004563:0.003257:0.003904:0.007608:0.007702:0.007173:0.007608:0.007644:0.003540:0.007173:0.004563:0.003257:0.003904:0.008032:0.007173:0.008055:0.003904:0.007608:0.003540:0.007644:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.003904:0.002352:0.007173:0.003257
acne. :@0.539155:0.508085:0.576127:0.508085:0.576127:0.495809:0.539155:0.495809:0.008032:0.007608:0.007173:0.007644:0.003257:0.003257
Dermatol Clin:@0.576127:0.508085:0.653855:0.508085:0.653855:0.495809:0.576127:0.495809:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352:0.003257:0.009560:0.002352:0.002352:0.007173
. 2019;37(1):1-9.:@0.653855:0.508085:0.741356:0.508085:0.741356:0.495809:0.653855:0.495809:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.003904:0.006515:0.003257
11. Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of de-:@0.519000:0.521554:0.923754:0.521554:0.923754:0.509279:0.519000:0.509279:0.006515:0.006515:0.003257:0.003869:0.008032:0.007150:0.008032:0.007173:0.007914:0.003046:0.006961:0.009560:0.003257:0.003034:0.009560:0.007173:0.007644:0.007173:0.007914:0.003034:0.006961:0.009560:0.003257:0.003034:0.002658:0.004563:0.007702:0.003986:0.003540:0.007644:0.003986:0.002352:0.007173:0.007702:0.002352:0.007173:0.003034:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003034:0.003692:0.007702:0.003540:0.003034:0.008032:0.007608:0.007173:0.007644:0.003046:0.008032:0.007173:0.008055:0.003046:0.003540:0.002352:0.004563:0.005903:0.003046:0.007702:0.003692:0.003034:0.008055:0.007644:0.003904
pression: A systematic review and meta-analysis:@0.539155:0.532456:0.808960:0.532456:0.808960:0.520181:0.539155:0.520181:0.008020:0.003540:0.007644:0.004563:0.004563:0.002352:0.007702:0.007173:0.003257:0.002705:0.008702:0.002705:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.002716:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.002705:0.008032:0.007173:0.008055:0.002705:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563
. J Am Acad Derma-:@0.808983:0.532456:0.923754:0.532456:0.923754:0.520181:0.808983:0.520181:0.003257:0.002705:0.005668:0.002705:0.008702:0.011030:0.002705:0.008702:0.007608:0.008032:0.008055:0.002705:0.008749:0.007644:0.003540:0.011030:0.008032:0.003904
tol:@0.539155:0.543357:0.553196:0.543357:0.553196:0.531082:0.539155:0.531082:0.003986:0.007702:0.002352
. 2017;76(6):1068-76 e9.:@0.553196:0.543357:0.684171:0.543357:0.684171:0.531082:0.553196:0.531082:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.007644:0.006515:0.003257
12. Oliveira JM, :@0.519000:0.556827:0.605007:0.556827:0.605007:0.544552:0.519000:0.544552:0.006279:0.006279:0.003022:0.004574:0.009984:0.002117:0.002117:0.006279:0.007408:0.002117:0.003304:0.007796:0.002446:0.005433:0.010572:0.003022:0.003257
et al. :@0.604196:0.556827:0.633994:0.556827:0.633994:0.544552:0.604196:0.544552:0.007408:0.003751:0.002446:0.007796:0.002117:0.003022:0.003257
Association of isotretinoin with depression and suicide: :@0.633182:0.556827:0.927023:0.556827:0.927023:0.544552:0.633182:0.544552:0.008467:0.004327:0.004327:0.007467:0.007373:0.002117:0.007796:0.003751:0.002117:0.007467:0.006938:0.002446:0.007467:0.003457:0.002446:0.002117:0.004327:0.007467:0.003751:0.003304:0.007408:0.003751:0.002117:0.006938:0.007467:0.002117:0.006938:0.002446:0.009537:0.002117:0.003751:0.006938:0.002446:0.007820:0.007408:0.007785:0.003304:0.007408:0.004327:0.004327:0.002117:0.007467:0.006938:0.002446:0.007796:0.006938:0.007820:0.002446:0.004327:0.006914:0.002117:0.007373:0.002117:0.007820:0.007408:0.003257:0.003257
A review of current literature. :@0.539155:0.567729:0.699834:0.567729:0.699834:0.555453:0.539155:0.555453:0.008467:0.003022:0.003304:0.007408:0.006279:0.002117:0.007408:0.009537:0.003022:0.007467:0.003457:0.003022:0.007373:0.006914:0.003304:0.003304:0.007408:0.006938:0.003751:0.003022:0.002117:0.002117:0.003751:0.007408:0.003304:0.007796:0.003751:0.006914:0.003304:0.007408:0.003022:0.003257
J Cutan Med Surg:@0.699599:0.567729:0.798376:0.567729:0.798376:0.555453:0.699599:0.555453:0.005433:0.003022:0.009325:0.006914:0.003751:0.007796:0.006938:0.003022:0.010572:0.007408:0.007820:0.003022:0.005621:0.006914:0.003304:0.007914
. 2018;22(1):58-64.:@0.798141:0.567729:0.894438:0.567729:0.894438:0.555453:0.798141:0.555453:0.003022:0.003022:0.006279:0.006279:0.006279:0.006279:0.003022:0.006279:0.006279:0.004104:0.006279:0.004104:0.003022:0.006279:0.006279:0.003669:0.006279:0.006279:0.003257
13. Gold MH, Baldwin H, Lin T. Management of comedonal acne vul-:@0.519000:0.581198:0.923742:0.581198:0.923742:0.568923:0.519000:0.568923:0.006515:0.006515:0.003257:0.003869:0.010254:0.007702:0.002352:0.008055:0.004668:0.010807:0.008032:0.003257:0.004668:0.006750:0.008032:0.002352:0.008055:0.009772:0.002352:0.007173:0.004668:0.008032:0.003257:0.004668:0.005433:0.002352:0.007173:0.004668:0.005009:0.003257:0.004657:0.010807:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.004657:0.007702:0.003692:0.004657:0.007608:0.007702:0.011030:0.007644:0.008055:0.007702:0.007173:0.008032:0.002352:0.004657:0.008032:0.007608:0.007173:0.007644:0.004657:0.006515:0.007150:0.002352:0.003904
garis  with  fixed-combination  topical  therapy. :@0.539155:0.592100:0.804985:0.592100:0.804985:0.579824:0.539155:0.579824:0.007914:0.008032:0.003540:0.002352:0.004563:0.003257:0.001940:0.009772:0.002352:0.003986:0.007173:0.003257:0.001940:0.002863:0.002863:0.005644:0.007644:0.008055:0.003904:0.007608:0.007702:0.011018:0.008020:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.001940:0.003986:0.007702:0.008020:0.002352:0.007608:0.008032:0.002352:0.003257:0.001940:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003257:0.003257
J Cosmet Dermatol.:@0.806925:0.592100:0.923765:0.592100:0.923765:0.579824:0.806925:0.579824:0.005668:0.005198:0.009560:0.007702:0.004563:0.011030:0.007644:0.003986:0.005198:0.008749:0.007644:0.003540:0.011030:0.008032:0.003986:0.007702:0.002352:0.003257
 :@0.923765:0.592100:0.927023:0.592100:0.927023:0.579824:0.923765:0.579824:0.003257
2018;17(2):227-31.:@0.539155:0.603001:0.639685:0.603001:0.639685:0.590726:0.539155:0.590726:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
14. Chien AL, :@0.519000:0.616471:0.597681:0.616471:0.597681:0.604195:0.519000:0.604195:0.006515:0.006515:0.003257:0.003869:0.009560:0.007173:0.002352:0.007644:0.007173:0.003975:0.008702:0.005433:0.003257:0.003257
et al:@0.598399:0.616471:0.624387:0.616471:0.624387:0.604195:0.598399:0.604195:0.007644:0.003986:0.003975:0.008032:0.002352
. Treatment of acne in pregnancy. :@0.624387:0.616471:0.826846:0.616471:0.826846:0.604195:0.624387:0.604195:0.003257:0.003975:0.005009:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003963:0.007702:0.003692:0.003975:0.008032:0.007608:0.007173:0.007644:0.003975:0.002352:0.007173:0.003975:0.008020:0.003540:0.007644:0.007914:0.007173:0.008032:0.007173:0.007608:0.006303:0.003257:0.003257
J Am Board Fam :@0.827586:0.616471:0.927011:0.616471:0.927011:0.604195:0.827586:0.604195:0.005668:0.003975:0.008702:0.011030:0.003975:0.006750:0.007702:0.008032:0.003540:0.008055:0.003975:0.005703:0.008032:0.011030:0.003257
Med.:@0.539155:0.627372:0.568918:0.627372:0.568918:0.615097:0.539155:0.615097:0.010807:0.007644:0.008055:0.003257
 2016;29(2):254-62.:@0.568918:0.627372:0.672705:0.627372:0.672705:0.615097:0.568918:0.615097:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
15. Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and :@0.519000:0.640842:0.926999:0.640842:0.926999:0.628567:0.519000:0.628567:0.006515:0.006515:0.003257:0.003869:0.006950:0.007702:0.007173:0.007914:0.003834:0.006961:0.005433:0.003257:0.003834:0.005009:0.007644:0.006303:0.003834:0.008032:0.005433:0.003257:0.003845:0.005009:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003834:0.007702:0.003692:0.003834:0.008032:0.007608:0.007173:0.007644:0.003834:0.006515:0.007150:0.002352:0.007914:0.008032:0.003540:0.002352:0.004563:0.003845:0.008055:0.007150:0.003540:0.002352:0.007173:0.007914:0.003834:0.008020:0.003540:0.007644:0.007914:0.007173:0.008032:0.007173:0.007608:0.006303:0.003834:0.008032:0.007173:0.008055:0.003257
lactation. :@0.539155:0.651743:0.596893:0.651743:0.596893:0.639468:0.539155:0.639468:0.002352:0.008032:0.007608:0.003986:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Drugs:@0.596893:0.651743:0.628808:0.651743:0.628808:0.639468:0.596893:0.639468:0.008749:0.003540:0.007150:0.007914:0.004563
. 2013;73(8):779-87.:@0.628808:0.651743:0.735852:0.651743:0.735852:0.639468:0.628808:0.639468:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
Oratane_Advert_mims_06/2019_R_p.indd   1:@1.023854:1.016384:1.226661:1.016384:1.226661:1.007862:1.023854:1.007862:0.007842:0.003356:0.005604:0.002802:0.005604:0.005604:0.005604:0.005604:0.006723:0.005604:0.005040:0.005604:0.003356:0.002802:0.005604:0.008396:0.002238:0.008396:0.005040:0.005604:0.005604:0.005604:0.002802:0.005604:0.005604:0.005604:0.005604:0.005604:0.007277:0.005604:0.005604:0.002802:0.002238:0.005604:0.005604:0.005604:0.002802:0.002802:0.002802:0.005604
2019/06/21   9:43 AM:@1.906261:1.016384:2.002639:1.016384:2.002639:1.007862:1.906261:1.007862:0.005604:0.005604:0.005604:0.005604:0.002802:0.005604:0.005604:0.002802:0.005604:0.005604:0.002802:0.002802:0.002802:0.005604:0.002802:0.005604:0.005604:0.002802:0.006723:0.008396